drugset / Trial / NCT06531356

Efficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population

NCT06531356 ↗

Phase 4 Completed 108 enrolled Kasr El Aini Hospital
RandomizedParallel-groupOpen-labelSupportive care

Summary

The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population. Investigator's aim is to know : quality of wound healing, rate of infection and time needed for complete healing. Participants will be divided into two groups. All participants will undergo cesarean section. We will inject autologous amniotic fluid in the edges of the wound during skin closure in half of the participants. Wound healing will be assessed at 1st, 2nd and 6th week postoperatively.

Timeline

Start
2024-02-16
Primary completion
2024-05-16
Completion
2024-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous amniotic fluid Unknown 10 ml —

Indications

No indication recorded.